| 摘要 |
The present invention provides an HDL comprising an agent selected from the group consisting of antiproteases, antioxidants, antimitotics, anti-apoptotic agents and agents involved in the iron metabolism for alleviating the deleterious effect of injection of recombinant tissue plasminogen activator by reducing the risk of haemorrhagic complications. |
